Custo-Efetividade da Teriparatida em Homens com Osteoporose Grave no Brasil
In the analyzed scenarios, the use of bisphosphonates produces resource savings in relation to teriparatide in the treatment of men. Teriparatide was not cost-effective in any situation.
Authors
- Gabriela Bittencourt González Mosegui (ORCID: https://orcid.org/0000-0001-5954-684X)
- Cid Manso de Mello Vianna (ORCID: https://orcid.org/0000-0003-0252-1144)
- Marcus Paulo da Silva Rodrigues (ORCID: https://orcid.org/0000-0002-6043-8528)
- Tácio de Mendonça Lima (ORCID: https://orcid.org/0000-0003-4395-2098)
- Tayna Felicíssimo Gomes de Souza Bandeira (ORCID: https://orcid.org/0009-0001-5032-8325)
Institutions
- Universidade Federal Fluminense (BR)
- Universidade do Estado do Rio de Janeiro (BR)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.vhri.2025.101553
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00